Pulmonary Arterial Capacitance Predicts 1-Year Survival but Not Change in 6-Minute Walk Distance in Pulmonary Arterial Hypertension

Trial Profile

Pulmonary Arterial Capacitance Predicts 1-Year Survival but Not Change in 6-Minute Walk Distance in Pulmonary Arterial Hypertension

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Mar 2016

At a glance

  • Drugs Beraprost (Primary) ; Treprostinil (Primary)
  • Indications Pulmonary arterial hypertension
  • Focus Adverse reactions; Biomarker; Therapeutic Use
  • Most Recent Events

    • 04 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top